Low Testosterone in Women: Signs, Causes, and What to Do About It
Testosterone is the most abundant biologically active hormone in women's bodies, produced by the ovaries and adrenal glands. Levels decline approximately 50 percent between the mid-20s and menopause, with continued decline thereafter.
Common signs of low testosterone in women include reduced libido, persistent fatigue, mood changes, brain fog, loss of muscle mass, joint discomfort, body composition changes, and reduced motivation. Most of these symptoms overlap with other conditions, which is why diagnosis requires careful evaluation rather than reliance on a single symptom.
Testosterone testing in women is more complex than in men because standard laboratory assays are less accurate at the low concentrations typical of female physiology. This is a real diagnostic challenge that affects how testosterone levels should be interpreted.
The causes of low testosterone in women include natural aging, menopause (natural or surgical), premature ovarian insufficiency, adrenal insufficiency, certain medications (especially oral contraceptives and oral estrogen), chronic illness, and chronic stress.
Most institutional medical sources state there is no formally recognized "low testosterone syndrome" in women, but this reflects a regulatory gap more than a clinical reality. Many women with low testosterone do experience meaningful symptoms that respond to appropriate treatment.
Before considering testosterone therapy, a thorough workup should rule out other causes of similar symptoms—thyroid dysfunction, depression, sleep disorders, iron deficiency, vitamin D deficiency, perimenopausal estrogen fluctuation, and adrenal issues are all common alternatives.
Treatment, when appropriate, typically involves transdermal testosterone cream at doses approximately one-tenth of those used in men, with ongoing physician monitoring and hormone testing to ensure levels remain in the normal female range.
Is This Normal?
If you're reading this, there's a reasonable chance you've experienced some combination of fatigue you can't explain, libido that's faded, mood that's shifted, mental sharpness that feels duller than it used to, or a body that doesn't respond the way it once did. Maybe you've been told this is "just getting older." Maybe you've been told to try a different antidepressant, get more sleep, exercise more. Maybe you've been told nothing at all.
These symptoms are real. They are not imagined, and they are not a personal failure. And in many women, they reflect a genuine, measurable biological shift—including, often, a decline in testosterone.
Low testosterone in women is one of the most under-recognized hormonal conditions in modern medicine. It has been historically overlooked because testosterone has been culturally classified as a "male hormone," and because the symptoms overlap with so many other common conditions that distinguishing causes requires careful clinical attention. But the biology is real: testosterone declines significantly across the female lifespan, and that decline contributes to a wide range of symptoms that meaningfully affect quality of life.
This article walks through what low testosterone looks like in women, what causes it, how it's diagnosed, what alternatives need to be ruled out, and what treatment options exist when low testosterone is the cause.
What Testosterone Does in Women
Testosterone in women is not a small or peripheral hormone. Before menopause, women produce three times as much testosterone as estrogen in absolute terms—making testosterone the most abundant biologically active hormone in the female body. It is produced primarily in the ovaries and adrenal glands, with peak production in the mid-20s and gradual decline thereafter.
Testosterone contributes to many systems women rely on daily:
- Sexual function: libido, arousal, orgasm, and overall sexual satisfaction
- Mood and motivation: sense of well-being, drive, emotional resilience
- Cognitive function: focus, processing speed, verbal memory
- Musculoskeletal health: muscle mass, bone density, joint comfort
- Body composition: lean tissue maintenance, fat distribution
- Cardiovascular function: vascular health, lipid profile
- Energy: physical stamina, daytime alertness
When testosterone declines, any or all of these systems can be affected. Because testosterone influences so many domains simultaneously, low testosterone often presents not as a single symptom but as a constellation of subtle changes that women initially dismiss or attribute to other causes.
Signs of Low Testosterone in Women
The symptoms of low testosterone in women are varied, often subtle, and frequently overlap with other conditions. Most women don't experience all of these symptoms; the pattern of which symptoms predominate often reflects which testosterone-influenced systems are most affected in that individual.
Reduced Libido and Sexual Function
The most clinically recognized symptom. Women with low testosterone often experience:
- Reduced or absent sexual desire
- Reduced sexual fantasy or interest
- Less responsive arousal
- Reduced intensity or absence of orgasm
- Less satisfaction with sexual activity
When these changes cause meaningful personal distress, they may meet criteria for hypoactive sexual desire disorder (HSDD), the indication with the strongest formal evidence for testosterone therapy in women.
Persistent Fatigue
Not the ordinary tiredness that comes from a busy week or insufficient sleep. Fatigue from low testosterone tends to:
- Persist despite adequate sleep
- Feel cumulative or unrelenting rather than situational
- Reduce stamina for both physical and cognitive tasks
- Make exercise harder to motivate or recover from
- Be accompanied by reduced overall vitality or "spark"
This pattern of fatigue is often dismissed or attributed to depression, but in many women it reflects a hormonal contribution that responds to addressing the underlying cause.
Mood Changes
Testosterone receptors are present throughout the brain, particularly in regions involved in mood regulation, motivation, and reward. Low testosterone may contribute to:
- Persistent low mood
- Increased irritability or emotional reactivity
- Reduced motivation or drive
- Difficulty feeling pleasure or interest in activities (anhedonia)
- Increased anxiety
- A general sense of "not feeling like yourself"
These symptoms are commonly misdiagnosed as primary mood disorders. While clinical depression can certainly coexist with low testosterone, the hormonal contribution to mood is real and often missed.
Cognitive Symptoms (Brain Fog)
Many women describe a phenomenon often called "brain fog"—mental sharpness that feels reduced compared to earlier life. Specific patterns include:
- Difficulty with word retrieval
- Slower processing speed
- Reduced ability to focus or concentrate
- Memory lapses, particularly for recent events
- Feeling like thinking takes more effort than it used to
Cognitive symptoms from low testosterone often overlap with perimenopausal cognitive changes and with the early stages of mood disorders, making careful evaluation important.
Loss of Muscle Mass and Strength
Testosterone contributes to muscle protein synthesis. As testosterone declines, women may notice:
- Reduced visible muscle definition
- Loss of strength, particularly for tasks that were previously easy
- Slower recovery from exercise
- Greater perceived effort during physical activity
- Reduced exercise tolerance
This is often gradual and easy to attribute to "just aging," but it reflects measurable changes in lean tissue that contribute to broader metabolic and functional decline if unaddressed.
Body Composition Changes
Related to muscle loss but extending beyond it. Common patterns include:
- Increased body fat percentage, particularly around the midsection
- Reduced metabolic rate (the body burns fewer calories at rest)
- Difficulty losing weight despite consistent effort
- Changes in how clothes fit even with stable scale weight
For midlife women, these changes often accelerate during the menopause transition, when the simultaneous decline of estrogen, progesterone, and testosterone collectively shifts body composition in unfavorable directions.
Joint Discomfort
One of the most under-recognized symptoms. Testosterone receptors are present in joint tissue, and many women report joint discomfort that emerges during the menopause transition—shoulder pain, finger stiffness, hip discomfort, knee aches—and is frequently dismissed as unrelated to hormones. This symptom often turns out to be hormonally responsive when appropriately addressed.
Sleep Disturbances
Although estrogen and progesterone play larger roles in sleep regulation than testosterone, sleep changes can be part of the low testosterone picture, particularly:
- Reduced sleep quality despite adequate sleep duration
- Early morning awakening
- Restless or non-restorative sleep
- Sleep that doesn't leave you feeling rested
Hair and Skin Changes
Testosterone influences both hair and skin biology. Low testosterone may contribute to:
- Thinning of pubic and underarm hair
- Reduced overall hair density on the scalp (though this can also reflect other causes)
- Changes in skin texture or quality
- Reduced skin oiliness
Reduced Sense of Well-Being
This is harder to define but consistently reported. Many women describe a vague sense of not feeling like themselves, reduced enjoyment of activities that used to bring pleasure, or a feeling that something is "off" without being able to identify a specific symptom. This pattern—a non-specific decline in vitality and well-being—is one of the more common presentations of low testosterone in clinical practice.
What Else Could It Be?
This is the question that careful evaluation has to answer before testosterone therapy becomes appropriate. Most of the symptoms above can have causes other than (or in addition to) low testosterone, and treating with testosterone without identifying the actual cause is not appropriate.
Common alternative explanations to rule out:
Thyroid Dysfunction
Hypothyroidism produces fatigue, weight gain, mood changes, cognitive slowing, hair thinning, and reduced cold tolerance—much of which overlaps with low testosterone symptoms. Basic thyroid testing (TSH, free T4, ideally free T3 and thyroid antibodies) is part of any reasonable workup for women presenting with these symptoms.
Depression and Anxiety Disorders
Primary mood disorders can produce all of the symptoms listed above and often coexist with hormonal imbalances. Distinguishing between depression contributing to symptoms versus symptoms contributing to depression often requires careful clinical assessment. Both can be true simultaneously.
Perimenopausal Hormonal Fluctuation
The menopause transition is characterized by erratic estrogen and progesterone levels alongside the more gradual testosterone decline. Many of the symptoms attributed to low testosterone are also caused by perimenopausal estrogen fluctuation. Often, both contribute, and both need to be addressed.
Sleep Disorders
Sleep apnea is meaningfully underdiagnosed in women and produces fatigue, cognitive symptoms, mood changes, and metabolic disruption. Restless legs syndrome, insomnia, and circadian rhythm disorders all contribute to symptoms that overlap with low testosterone.
Iron Deficiency and Anemia
Common in women, particularly those who are still menstruating. Produces fatigue, cognitive symptoms, reduced exercise tolerance, and mood changes. Basic iron studies (ferritin, iron, TIBC, hemoglobin) should be part of any workup for women with these symptoms.
Vitamin D Deficiency
Increasingly common and produces fatigue, mood changes, joint discomfort, and reduced overall vitality. Simple to test and address.
Adrenal Issues
Less common but important to consider. Adrenal insufficiency reduces production of DHEA (the adrenal androgen precursor) and cortisol, producing fatigue, mood changes, and metabolic symptoms. Chronic stress can produce dysregulated cortisol patterns with similar effects.
Medication Side Effects
Several common medications can produce symptoms similar to low testosterone:
- Oral contraceptives reduce circulating testosterone availability
- Oral estrogen (in contrast to transdermal) can raise sex hormone binding globulin and reduce free testosterone
- Some antidepressants (particularly SSRIs) can reduce libido and energy
- Statins can affect mood and energy in some women
- Beta-blockers can produce fatigue and reduced libido
Other Endocrine Conditions
Polycystic ovary syndrome (PCOS) often presents with elevated rather than low testosterone, but the symptoms can overlap in confusing ways. Cushing syndrome, hyperprolactinemia, and pituitary disorders can all produce overlapping symptoms.
The key takeaway: a workup for suspected low testosterone in women should include evaluation for these alternatives. Treating with testosterone without ruling them out can mean missing the actual cause of symptoms or compounding the issue.
Why Testosterone Levels Decline in Women
The decline in testosterone across the female lifespan has several drivers, some inevitable and some modifiable.
Natural Aging
Testosterone production peaks in the mid-20s and declines progressively thereafter. By age 40, circulating testosterone in many women is approximately half of peak levels. This decline is part of normal aging biology and continues through menopause and beyond.
Menopause (Natural and Surgical)
The menopause transition contributes additional testosterone decline beyond the gradual age-related drop. Natural menopause is accompanied by ongoing testosterone decline as ovarian function diminishes. Surgical menopause—removal of both ovaries (bilateral oophorectomy)—produces an immediate and substantial drop in testosterone, often more pronounced than the testosterone deficit experienced in natural menopause.
Premature Ovarian Insufficiency
Affects approximately 1 percent of women under 40. The early decline in ovarian function reduces production of all ovarian hormones, including testosterone.
Oral Contraceptives
Combined oral contraceptive pills can substantially reduce testosterone availability. They suppress ovarian production and raise levels of sex hormone binding globulin (SHBG), which binds testosterone in circulation and reduces its biologically active free fraction. Many women on oral contraceptives experience symptoms of low testosterone—particularly reduced libido—without recognizing the connection.
Oral Estrogen Therapy
Oral (as opposed to transdermal) estrogen replacement also raises SHBG, with similar implications for free testosterone availability. This is one reason transdermal estrogen is increasingly preferred over oral formulations.
Adrenal Conditions
The adrenal glands produce roughly half of women's testosterone (through conversion of DHEA). Adrenal insufficiency, whether primary (Addison's disease) or secondary, can substantially reduce testosterone production.
Chronic Illness and Inflammation
Chronic medical conditions, chronic stress, and ongoing inflammation can all suppress testosterone production through their effects on the hypothalamic-pituitary-adrenal axis and on adrenal function.
Some Medications
Glucocorticoids (prednisone and similar), some opioids, and certain other medications can suppress testosterone production over time.
How Low Testosterone Is Tested
Testing testosterone in women is more complicated than testing in men, and it's worth understanding why before getting tested.
The Assay Accuracy Problem
Standard laboratory testosterone assays were developed primarily for men, whose testosterone levels are roughly ten times higher than women's. At the lower concentrations typical of female physiology, these standard assays are less accurate—particularly at the lower end of the female range, where the distinction between "low" and "normal" matters most clinically.
This is a real diagnostic limitation. A testosterone level reported as "30 ng/dL" in a woman could in reality be anywhere from 20 to 40 ng/dL depending on the assay used and its sensitivity at low concentrations. For testing in women, more sensitive methods—particularly liquid chromatography-mass spectrometry (LC-MS)—provide more reliable results than the standard immunoassays used in many basic panels.
What to Test
A reasonable workup for suspected low testosterone in women typically includes:
- Total testosterone (ideally measured by LC-MS for accuracy)
- Free testosterone (the biologically active fraction not bound to SHBG)
- Sex hormone binding globulin (SHBG) (to interpret total vs. free testosterone)
- DHEA-sulfate (DHEA-S) (the adrenal androgen precursor)
- Estradiol (to understand the broader hormonal picture)
- TSH and free T4 (to rule out thyroid dysfunction)
- Complete metabolic panel and CBC (to rule out anemia and basic metabolic issues)
- Ferritin (to assess iron stores)
- Vitamin D (25-hydroxyvitamin D)
A more comprehensive panel often includes progesterone, prolactin, cortisol, and additional thyroid markers, particularly for women with complex symptom patterns or suspected multiple endocrine issues.
Interpreting Results
The reference range for total testosterone in adult women is approximately 15 to 70 ng/dL, though laboratory ranges vary. A few key points about interpretation:
- "Within range" doesn't necessarily mean "optimal." Some women experience meaningful symptoms at the lower end of the reference range and feel substantially better when their levels are restored to the upper end of normal.
- Free testosterone is often more clinically relevant than total testosterone, particularly for women on oral contraceptives or oral estrogen, where SHBG elevation can mask functional androgen deficiency.
- Testosterone level alone does not establish clinical significance. The combination of symptoms, individual biology, and laboratory results is what determines whether low testosterone is clinically meaningful for a particular woman.
For a comprehensive testosterone and hormone evaluation, see Healthspan's Complete Female Hormone Panel.
"Is Low Testosterone a Real Medical Condition in Women?"
This is a question many women encounter when researching their symptoms, and it's worth addressing directly.
Most institutional medical sources state that there is no formally recognized "low testosterone syndrome" in women. The Endocrine Society and several other major medical bodies have explicitly stated that testing testosterone in women without specific clinical indications is not recommended, and that treating low testosterone in women is appropriate only for HSDD in postmenopausal women.
This framing reflects a real regulatory and evidence situation. The randomized trial evidence base for testosterone in women has focused predominantly on sexual function endpoints, which is what has driven the formal endorsements that exist. For other symptoms, the trial evidence is less developed.
But "no formally recognized syndrome" is not the same as "the symptoms aren't real" or "treatment doesn't work." The biology is real. Testosterone receptors are present throughout the female body. Testosterone declines measurably with age and during menopause. Many women report meaningful improvements in mood, energy, cognitive function, joint comfort, and body composition on appropriately dosed testosterone therapy—even where the formal trial evidence supporting these effects is still being developed.
The disconnect between formal regulatory frameworks and clinical experience is increasingly being recognized as a research and training gap rather than as evidence that the effects don't exist. The 2026 British Menopause Society Tool for Clinicians on testosterone replacement explicitly notes that "some individuals report improvement" of cognitive, mood, energy, and musculoskeletal symptoms on testosterone therapy, while calling for better-designed trials to formally establish these effects [1].
For women experiencing symptoms that may reflect low testosterone, the practical implication is this: the absence of a formally recognized syndrome doesn't mean the symptoms aren't real or that treatment doesn't help. It means that working with a clinician familiar with off-label use of testosterone for women, who takes an evidence-graded approach to both diagnosis and treatment, is often necessary to navigate the gap.
Treatment: When and How
When low testosterone is identified, the workup has appropriately ruled out alternative causes, and the symptom picture warrants intervention, treatment options are reasonably well-established.
Lifestyle Foundations First
Before pharmacological intervention, several lifestyle factors meaningfully affect testosterone and related symptoms:
- Sleep optimization. Sleep restriction reduces testosterone in both sexes. Most adults benefit from 7 to 9 hours of consistent sleep.
- Strength training. Resistance exercise supports testosterone and broader hormonal health, alongside its direct benefits for muscle and bone.
- Adequate protein intake. Many women under-consume protein relative to their needs, particularly in midlife. Protein adequacy supports lean mass and overall metabolic function.
- Stress management. Chronic stress dysregulates the hypothalamic-pituitary-adrenal axis, suppressing testosterone production.
- Avoiding oral contraceptives or oral estrogen if they're contributing. Switching to a non-hormonal contraceptive option or to transdermal estrogen can sometimes resolve hormonal symptoms.
For women with mild symptoms and clear contributing lifestyle factors, addressing these foundations is often sufficient.
Testosterone Therapy
When symptoms persist despite lifestyle optimization and when testosterone levels are low alongside relevant symptoms, testosterone replacement may be appropriate.
The standard approach for women in the United States is transdermal testosterone cream, prescribed at approximately one-tenth of male doses. A typical starting dose is 0.5 mL daily applied to skin, with adjustment based on lab response. The goal is to maintain circulating testosterone within the normal female premenopausal range.
For a deeper treatment of how testosterone therapy works for women, see our comprehensive guide to testosterone treatment for women.
For menopause-specific considerations, see our testosterone therapy for menopause guide.
What to Expect from Treatment
When testosterone therapy is appropriate, women generally notice changes on different timelines depending on which symptoms predominate:
- Mood, energy, and sleep: 2 to 4 weeks
- Libido and sexual function: 6 to 12 weeks
- Cognitive clarity and joint comfort: 4 to 12 weeks
- Body composition (lean mass, fat distribution): Months to a year
Most clinicians recommend at least 3 to 4 months at appropriate dose before evaluating overall response.
What to Avoid
A few things to be cautious about when researching treatment options:
- Testosterone pellet therapy is generally not recommended for women. Pellets produce testosterone levels well above the female physiological range, cannot be adjusted once implanted, and are responsible for most documented serious side effects in women.
- Over-the-counter "testosterone boosters" are not FDA-approved and generally lack reliable evidence of efficacy. Some contain ingredients with their own safety considerations.
- DHEA supplementation may help some women but is sold without medical oversight in the United States. Effects on testosterone levels are variable, and DHEA can produce androgenic side effects similar to testosterone itself.
- Male-dosed testosterone products used at male doses are not appropriate for women. Some practitioners use very small fractions of male doses off-label, but this requires careful titration.
Frequently Asked Questions
What are the most common signs of low testosterone in women?
The most common signs include reduced libido, persistent fatigue, mood changes, brain fog, reduced muscle mass and strength, joint discomfort, changes in body composition, and a general reduced sense of well-being. Most women don't experience all of these symptoms simultaneously; the pattern depends on which testosterone-influenced systems are most affected.
At what age does testosterone start declining in women?
Testosterone production peaks in the mid-20s and declines progressively thereafter. By age 40, circulating testosterone in many women is approximately half of peak levels. The decline accelerates during the menopause transition (typically late 40s to mid-50s) and continues into postmenopause.
Can young women have low testosterone?
Yes. Causes in younger women include oral contraceptive use (which reduces testosterone availability), premature ovarian insufficiency, adrenal conditions, chronic illness, chronic stress, and certain medications. Younger women with symptoms suggesting low testosterone benefit from thorough hormonal evaluation rather than dismissal as "too young" to have hormone-related symptoms.
How is low testosterone diagnosed in women?
Diagnosis combines symptom assessment, laboratory testing, and exclusion of alternative causes. Laboratory testing typically includes total and free testosterone (ideally by LC-MS for accuracy), SHBG, DHEA-S, estradiol, and screening for alternative causes (thyroid function, complete blood count, iron studies, vitamin D, comprehensive metabolic panel).
Why is testing testosterone in women considered unreliable?
Standard laboratory testosterone assays were developed for men and are less accurate at the lower concentrations typical of female physiology. The distinction between "low" and "normal" matters most at the lower end of the female range, which is exactly where standard assays are least accurate. Liquid chromatography-mass spectrometry (LC-MS) provides more reliable measurements but is not always used in basic panels.
What's a normal testosterone level for women?
The reference range for total testosterone in adult women is approximately 15 to 70 ng/dL, though laboratory ranges vary. "Normal" range varies with age, life stage, and individual biology. Many women feel best at the upper end of the normal range, and being "within range" does not necessarily mean optimal for symptoms.
Can low testosterone in women cause depression?
Testosterone influences mood through its effects on brain regions involved in mood regulation, motivation, and reward. Low testosterone can contribute to depressive symptoms in women, though primary mood disorders frequently coexist with hormonal imbalances. Distinguishing between hormonal contribution to mood symptoms versus primary depression requires careful clinical evaluation; both can be true simultaneously.
Does low testosterone cause weight gain in women?
Indirectly, yes. Low testosterone contributes to reduced lean muscle mass, which reduces basal metabolic rate, which can lead to gradual fat accumulation. It also contributes to body composition shifts toward central/visceral fat distribution. The weight gain is typically gradual rather than dramatic, and is often more about composition (more fat, less muscle) than about scale weight alone.
Can low testosterone cause joint pain?
Many women report improvement in joint discomfort with appropriate testosterone therapy. Testosterone receptors are present in joint tissue, and the joint discomfort that frequently emerges during perimenopause and menopause may have a testosterone-related component. This symptom is often under-recognized as hormonally responsive.
Does birth control cause low testosterone in women?
Yes, often. Combined oral contraceptive pills suppress ovarian testosterone production and raise sex hormone binding globulin (SHBG), which binds testosterone and reduces its biologically active free fraction. Many women on oral contraceptives experience symptoms of low testosterone—particularly reduced libido—without recognizing the connection. Switching to non-hormonal contraception sometimes resolves these symptoms over weeks to months.
What happens to testosterone after menopause?
Testosterone continues to decline after menopause, though more gradually than the estrogen decline that defines menopause itself. After natural menopause, the ovaries continue to produce some testosterone, but at reduced levels. After surgical menopause (removal of both ovaries), testosterone drops more abruptly and substantially.
Is testosterone therapy for women safe?
At physiologic doses with appropriate monitoring, testosterone therapy is generally well-tolerated. Side effects are usually mild and reversible at proper doses. Safety risks increase substantially at doses exceeding the female physiological range. Pellet therapy is responsible for most documented serious side effects in women and is generally not recommended.
How long does it take testosterone therapy to work in women?
Different effects emerge on different timelines. Mood, energy, and sleep changes can appear within 2 to 4 weeks. Libido and sexual function effects typically take 6 to 12 weeks. Cognitive and joint comfort effects emerge over 4 to 12 weeks. Body composition changes take months to a year. Most clinicians recommend trying testosterone therapy for at least 3 to 4 months before evaluating overall response.
Where can I get tested for low testosterone?
Through any healthcare provider willing to order the appropriate panel, including primary care physicians, gynecologists, endocrinologists, and women's-health-focused telemedicine providers. The key is ensuring the panel includes free testosterone and SHBG in addition to total testosterone, and ideally uses LC-MS methodology for accuracy. Healthspan offers a Complete Female Hormone Panel that includes the relevant testing.
Should I see a specialist or my primary care doctor?
Both can be appropriate starting points. Primary care physicians can order initial testing and rule out common alternative causes (thyroid, anemia, vitamin deficiencies). If symptoms persist despite addressing these or if testosterone therapy is being considered, working with a clinician specifically experienced in women's hormone therapy is often valuable, given the off-label nature of treatment and the dosing nuance required.
How Healthspan Approaches Low Testosterone in Women
The Healthspan Women's Hormone Health Program provides physician-supervised evaluation and treatment for women with symptoms that may reflect low testosterone or broader hormonal imbalances. Our approach includes:
- Comprehensive hormonal evaluation. Our Complete Female Hormone Panel includes total and free testosterone, estradiol, progesterone, DHEA-S, thyroid function, and other relevant markers to provide a full picture rather than testosterone alone
- Workup for alternative causes. Symptoms suggestive of low testosterone overlap with many other conditions, and our clinical evaluation includes screening for thyroid dysfunction, iron deficiency, vitamin D deficiency, and other common alternatives
- Individualized treatment decisions. When testosterone therapy is appropriate, treatment is typically transdermal testosterone cream at individualized dosing, with ongoing monitoring to maintain physiologic levels
- Coordinated hormone replacement. For women whose symptoms reflect broader hormonal imbalance, our clinicians coordinate testosterone therapy with estrogen, progesterone, and other interventions as appropriate
- Health coaching. Dedicated coach support addressing sleep, nutrition, movement, and stress as contributors to hormonal health
Membership pricing starts at $99 per month on a three-month plan or $129 for a single month. Lab work and medication are billed separately when ordered.
Conclusion
Low testosterone in women has been one of the most overlooked hormonal conditions in modern medicine—dismissed as "not a real syndrome," confused with other conditions, and often left untreated even when it is the actual cause of women's symptoms.
The biology is real. Testosterone is the most abundant biologically active hormone in the female body, declines significantly with age and during menopause, and contributes to a range of symptoms that affect quality of life across multiple domains. When testosterone is genuinely low and is contributing to symptoms, appropriately dosed treatment can produce meaningful improvements.
But not every fatigue, mood change, or libido issue reflects low testosterone. Thoughtful evaluation—including consideration of thyroid function, iron status, sleep, perimenopausal estrogen fluctuation, mood disorders, and medication effects—is essential before attributing symptoms to testosterone alone. The right approach is rarely "test testosterone, treat if low." It is "evaluate comprehensively, identify the actual contributors, and address them in proportion to their role."
For women whose symptoms have been dismissed or attributed to inevitable aging, the most important first step is to find a clinician who takes the symptoms seriously and is willing to do a thorough evaluation. Whether testosterone therapy is ultimately the right answer or not, women experiencing meaningful changes in their well-being deserve to have those changes properly investigated and, where possible, addressed.
Related Research
- British Menopause Society. (2026). Tool for Clinicians: Testosterone Replacement in Menopause. https://thebms.org.uk/wp-content/uploads/2026/05/08-NEW-BMS-TfC-Testosterone-replacement-in-menopause-MAY2026-A.pdf
- Davis, S. R., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., Parish, S. J., Pinkerton, J., Rymer, J., Simon, J. A., Vignozzi, L., & Wierman, M. E. (2019). Global consensus position statement on the use of testosterone therapy for women. Journal of Clinical Endocrinology and Metabolism, 104(10), 4660–4666. https://academic.oup.com/jcem/article/104/10/4660/5556103
- Davis, S. R., Azene, Z. N., Tonkin, A. M., Woods, R. L., McNeil, J. J., & Islam, R. M. (2024). Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study. Climacteric, 27(3), 282–288. https://pubmed.ncbi.nlm.nih.gov/38334088/
- Islam, R. M., Bell, R. J., Green, S., Page, M. J., & Davis, S. R. (2019). Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. The Lancet Diabetes & Endocrinology, 7(10), 754–766. https://doi.org/10.1016/S2213-8587(19)30189-5
- Cleveland Clinic. (2025). Low Testosterone in Women: Symptoms, Causes & Treatment. https://my.clevelandclinic.org/health/diseases/24897-low-testosterone-in-women
- Hemachandra, C., Islam, R. M., Bell, R. J., Sultana, F., & Davis, S. R. (2023). The association between testosterone and depression in postmenopausal women: A systematic review of observational studies. Maturitas, 168, 62–70.
Related studies